[go: up one dir, main page]

ATE331025T2 - Medium für die protein- und serumfreie zellkultur - Google Patents

Medium für die protein- und serumfreie zellkultur Download PDF

Info

Publication number
ATE331025T2
ATE331025T2 AT00969319T AT00969319T ATE331025T2 AT E331025 T2 ATE331025 T2 AT E331025T2 AT 00969319 T AT00969319 T AT 00969319T AT 00969319 T AT00969319 T AT 00969319T AT E331025 T2 ATE331025 T2 AT E331025T2
Authority
AT
Austria
Prior art keywords
medium
protein
cell culture
serum free
free cell
Prior art date
Application number
AT00969319T
Other languages
English (en)
Inventor
Manfred Reiter
Wolfgang Mundt
Friedrich Dorner
Leopold Grillberger
Artur Mitterer
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3518214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE331025(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of ATE331025T2 publication Critical patent/ATE331025T2/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT00969319T 1999-09-28 2000-09-27 Medium für die protein- und serumfreie zellkultur ATE331025T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0165999A AT409379B (de) 1999-06-02 1999-09-28 Medium zur protein- und serumfreien kultivierung von zellen

Publications (1)

Publication Number Publication Date
ATE331025T2 true ATE331025T2 (de) 2006-07-15

Family

ID=3518214

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0165999A AT409379B (de) 1999-06-02 1999-09-28 Medium zur protein- und serumfreien kultivierung von zellen
AT00969319T ATE331025T2 (de) 1999-09-28 2000-09-27 Medium für die protein- und serumfreie zellkultur

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT0165999A AT409379B (de) 1999-06-02 1999-09-28 Medium zur protein- und serumfreien kultivierung von zellen

Country Status (21)

Country Link
US (6) US20030203448A1 (de)
EP (1) EP1220893B2 (de)
JP (6) JP5441288B2 (de)
CN (2) CN101173246B (de)
AT (2) AT409379B (de)
AU (1) AU780791B2 (de)
CA (1) CA2385299A1 (de)
CY (1) CY1106135T1 (de)
CZ (1) CZ305307B6 (de)
DE (1) DE60028989T3 (de)
DK (1) DK1220893T4 (de)
ES (1) ES2265991T5 (de)
HU (1) HU228210B1 (de)
IL (4) IL148642A0 (de)
PL (1) PL215234B1 (de)
PT (1) PT1220893E (de)
RU (3) RU2380412C2 (de)
SI (1) SI1220893T1 (de)
SK (1) SK288059B6 (de)
TR (1) TR200200757T2 (de)
WO (1) WO2001023527A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) * 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
CN1596302A (zh) * 2001-11-28 2005-03-16 桑多斯有限公司 细胞培养方法
US7195905B2 (en) 2001-12-10 2007-03-27 Baxter Healthcare S.A. Enveloped virus vaccine and method for production
JP3916516B2 (ja) * 2002-06-10 2007-05-16 独立行政法人科学技術振興機構 硬組織−軟組織界面再生用足場材料
NZ538094A (en) * 2002-07-09 2007-01-26 Baxter Int Serum free and animal protein free culture medium for cultivation of cells
AU2004312352B2 (en) * 2003-12-19 2010-08-19 Wyeth Serum-free vero cell banking process
US7553665B2 (en) * 2004-03-01 2009-06-30 Ares Trading S.A. Process for the cultivation of mammalian cells producing IL-18BP in serum-free cell culture medium
AU2011221414B2 (en) * 2004-10-29 2012-09-20 Takeda Pharmaceutical Company Limited Animal Protein-Free Media for Cultivation of Cells
US20060094104A1 (en) * 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
EP1812557A4 (de) * 2004-10-29 2009-11-04 Centocor Ortho Biotech Inc Chemisch definierte medienzusammensetzungen
FR2879214A1 (fr) * 2004-12-14 2006-06-16 Pierre Fabre Medicament Sa Fractions peptidiques favorisant la croissance et la synthese de produit(s) d'interet en culture de cellules et/ou de tissus
JP5523674B2 (ja) * 2005-02-11 2014-06-18 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 植物タンパク質加水分解産物を含有する血清フリーの細胞培養液におけるポリペプチドの生産
WO2006095431A1 (ja) 2005-03-10 2006-09-14 Kyoritsu Seiyaku Corporation 動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
EP1707634A1 (de) 2005-03-29 2006-10-04 Octapharma AG Verfahren zur Isolierung von rekombinant hergestellten Proteinen
KR100670105B1 (ko) 2005-06-29 2007-01-17 주식회사 셀트리온 콩가수분해물의 저분자량 분획을 이용하여 시알산 함량이증가된 에리스로포이에틴을 생산하는 방법 및 그에 의하여생산된 시알산 함량이 증가된 에리스로포이에틴
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
PT2522717E (pt) 2006-01-04 2014-05-15 Baxter Healthcare Sa Meios de cultura celulares livres de oligopeptídeos
CA2644926A1 (en) * 2006-03-06 2007-09-13 Humagene, Inc. A method for the preparation of recombinant human thrombin and fibrinogen
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
EP2500416A1 (de) 2006-09-13 2012-09-19 Abbott Laboratories Verbesserungen an Zellkulturen
WO2008063472A2 (en) * 2006-11-13 2008-05-29 Schering Corporation Method for reducing protease activity in plant hydrolysate
WO2008073425A2 (en) 2006-12-11 2008-06-19 Schering Corporation High-sensitivity proteolysis assay
EP1988101A1 (de) * 2007-05-04 2008-11-05 Novo Nordisk A/S Verbesserung von Faktor-VIII-Polypeptid-Titern in Zellkulturen
KR101258949B1 (ko) 2007-06-15 2013-04-30 재단법인 목암생명공학연구소 활성형 재조합 혈액응고 9인자의 대량생산 방법
WO2009115495A1 (de) * 2008-03-19 2009-09-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zur steigerung der reklonierungseffizienz
WO2009127098A1 (zh) 2008-04-18 2009-10-22 上海中信国健药业有限公司 一种浓缩培养液及其使用方法
TW201012930A (en) 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
JP5458536B2 (ja) * 2008-09-17 2014-04-02 不二製油株式会社 乳酸の製造方法及び乳酸発酵用添加剤
RU2011116319A (ru) * 2008-09-26 2012-11-10 Шеринг Корпорейшн (US) Производство высокого титра антител
CA2742107A1 (en) * 2008-11-12 2010-05-20 Baxter International Inc. Method of producing serum-free insulin-free factor vii
EP2373783B1 (de) 2008-12-30 2017-11-01 Baxalta GmbH Verfahren zur verbesserung des zellwachstums unter verwendung von alkyl-amin-n-oxid (annox)
CN101603026B (zh) * 2009-06-19 2011-01-19 华东理工大学 适于动物细胞产品生产的无动物来源低蛋白培养基
US8313926B2 (en) 2009-07-31 2012-11-20 Baxter International Inc. Methods for expressing ADAMTS proteins in cell culture medium supplemented with zinc
CN102115728B (zh) * 2009-12-31 2012-09-26 北京清大天一科技有限公司 无血清动物细胞培养基干粉、液体培养基及其制备方法
RU2644651C2 (ru) * 2010-04-26 2018-02-13 Новартис Аг Среда для культивирования клеток
ES2870469T3 (es) 2010-04-26 2021-10-27 Novartis Procedimiento para el cultivo de células CHO.
EA029503B1 (ru) 2010-07-08 2018-04-30 Баксалта Инкорпорейтид Способ получения рекомбинантного adamts13 в культуре клеток
CN101914485A (zh) * 2010-08-05 2010-12-15 乐能生物工程股份有限公司 一种无血清大豆蛋白肽动物细胞培养基的配制方法
US20130224855A1 (en) 2010-08-31 2013-08-29 Abhishek Gupta Culture medium for eukaryotic cells
PL2625262T3 (pl) * 2010-10-05 2016-05-31 Novo Nordisk Healthcare Ag Sposób wytwarzania białka
EP2702077A2 (de) 2011-04-27 2014-03-05 AbbVie Inc. Verfahren zur steuerung des galactosylierungsprofil von rekombinant exprimierten proteinen
CN103160458A (zh) * 2011-12-15 2013-06-19 西南民族大学 一种适合Vero细胞生长的低血清培养基
WO2013133714A1 (en) * 2012-03-08 2013-09-12 Friesland Brands B.V. Culture medium for eukaryotic cells
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
CN104593317B (zh) * 2013-10-31 2018-05-04 中国食品发酵工业研究院 一种用于细胞培养基的大豆活性肽添加剂
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US10527551B2 (en) 2013-12-30 2020-01-07 Baxalta Incorporated Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use
RU2558253C1 (ru) * 2014-02-10 2015-07-27 Федеральное Казенное Предприятие " Щелковский Биокомбинат" Питательная среда для суспензионного культивирования клеток млекопитающих
EP4372078A3 (de) 2014-06-04 2024-09-04 Amgen Inc. Verfahren zur gewinnung von säugetierzellkulturen
TWI743024B (zh) 2014-06-06 2021-10-21 美商健臻公司 灌注培養方法及其用途
CN104560893B (zh) * 2015-01-30 2017-11-14 肇庆大华农生物药品有限公司 一种用于培养病毒的培养基及其制备方法
RU2588666C1 (ru) * 2015-03-23 2016-07-10 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский и технологический институт биологической промышленности" Компонент питательной среды для культивирования клеток млекопитающих
CN105002242A (zh) * 2015-07-23 2015-10-28 苏州康聚生物科技有限公司 用于cho细胞中高效表达重组人促甲状腺激素的无血清培养基及其应用
WO2017023689A1 (en) * 2015-07-31 2017-02-09 Zen-Bio, Inc. Exosome compositions and use thereof for soft tissue repair
TW202440904A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法（二）
SG11201900231RA (en) * 2016-07-19 2019-02-27 Accellta Ltd Culture media for culturing pluripotent stem cells in suspension
US11070703B2 (en) * 2016-07-29 2021-07-20 Robert Bosch Tool Corporation 3D printer touchscreen interface lockout
JP6258536B1 (ja) 2017-03-03 2018-01-10 協和発酵キリン株式会社 ダルベポエチン組成物の製造方法およびダルべポエチン産生細胞の培養方法
US20190010531A1 (en) * 2017-07-06 2019-01-10 Regeneron Pharmaceuticals, Inc. Cell culture process for making a glycoprotein
CN113151183A (zh) * 2021-04-21 2021-07-23 赵峻岭 一种促进蛋白表达的培养基添加物及其应用
WO2024024671A1 (ja) * 2022-07-27 2024-02-01 不二製油グループ本社株式会社 動物細胞増殖促進剤

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT165999B (de) 1947-06-26 1950-05-25 Delle Atel Const Electr Einirchtung zum Schutz von Drehstrommotoren gegen Überstrom
FR2196386A1 (en) 1972-08-17 1974-03-15 Cudennec Alain Culture media selection - for identification of unknown bacteria
US4443540A (en) 1980-05-09 1984-04-17 University Of Illinois Foundation Protein hydrolysis
DK207980A (da) * 1980-05-13 1981-11-14 Novo Industri As Fremgangsmaade til fremstilling af et skumnings- eller emulgeringsmiddel paa sojaproteinbasis
US4767704A (en) * 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
NZ210501A (en) 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
IL74909A (en) 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
EP0217822B1 (de) 1985-02-13 1993-05-12 Scios Nova Inc. Menschlicher metallothionein ii-promotor in säugetierexpressionssystemen
US4978616A (en) * 1985-02-28 1990-12-18 Verax Corporation Fluidized cell cultivation process
ZA862768B (en) 1985-04-17 1986-12-30 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB8608020D0 (en) 1986-04-02 1986-05-08 Beecham Group Plc Compounds
EP0318487B1 (de) 1986-08-04 1993-10-13 The University Of New South Wales Serumfreies gewebekulturmedium, das ein polymerzellenschutzmittel enthält
WO1989000192A1 (en) 1987-06-30 1989-01-12 Amgen Inc. Production of kallikrein
US5024947A (en) * 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP2507882B2 (ja) 1988-02-17 1996-06-19 工業技術院長 外部増殖因子非依存性増殖良好細胞株の製造法
US6048728A (en) * 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
JP2815613B2 (ja) 1989-03-24 1998-10-27 株式会社リコー 静電荷像現像用トナー
US5573937A (en) 1989-12-07 1996-11-12 Snow Brand Milk Products Co., Ltd. Serum free culture medium
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
AT393356B (de) 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
WO1991010726A1 (en) * 1990-01-22 1991-07-25 The United States Of America, Represented By The Secretary, United States Department Of Commerce Co-independent growth medium for maintenance and propagation of cells
JP2844484B2 (ja) * 1990-02-22 1999-01-06 味の素株式会社 組換え蛋白質の生産方法
JP2859679B2 (ja) 1990-03-01 1999-02-17 協和醗酵工業株式会社 新規細胞株
US5378612A (en) 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
JP2696001B2 (ja) 1991-04-15 1998-01-14 財団法人化学及血清療法研究所 組換え蛋白質産生用培地
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
JPH04228066A (ja) 1990-10-23 1992-08-18 Rikagaku Kenkyusho 外来遺伝子発現用培養細胞
EP0531562A1 (de) * 1991-09-11 1993-03-17 Doerr, Hans-Wilhelm, Prof. Dr. med. Kultivierung von Säugetierzellen
JPH05123178A (ja) * 1991-11-01 1993-05-21 Ajinomoto Co Inc Ｌ−フエニルアラニンの製造法
DK53792D0 (da) 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
RU2057176C1 (ru) 1992-05-20 1996-03-27 Институт генетики АН Республики Молдова Питательная среда для культивирования клеток человека и животных
DE4313620A1 (de) 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
AU7895898A (en) 1993-04-26 1998-10-08 Hans Wolf Mammal cell lines and method of obtaining glycoproteins
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
JP2766165B2 (ja) * 1993-08-02 1998-06-18 株式会社バイオポリマー・リサーチ バクテリアセルロースの製造方法
CN1088984A (zh) * 1993-11-11 1994-07-06 江西省医学科学研究所 一种用于造血祖细胞培养的无血清培养基
US5719050A (en) 1993-12-24 1998-02-17 Eiken Chemical Co., Ltd. Animal cell culturing media containing N-acetyl-L-glutamic acid
EP0666312A1 (de) 1994-02-08 1995-08-09 Wolfgang A. Renner Verfahren zur Förderung des Wachstums von Säugetierzellen
US5789247A (en) 1994-04-01 1998-08-04 Ballay; Annick Expression in non-tumoral human lymphoblastoid lines with an integrative vector
JP2684521B2 (ja) 1994-08-19 1997-12-03 ハムス株式会社 ベルトループ縫付けミシンにおけるテープ折り曲げ端の形成維持方法及びその装置
EP0733100A1 (de) 1994-09-09 1996-09-25 Wolfgang A. Renner Chemisches verfahren zur förderung der proliferation von tierischen zellen
EP2290053A1 (de) 1994-11-10 2011-03-02 Baxter Healthcare S.A. Verfahren zur Herstellung von Influenzaviren in protein-freiem Zellkulturmedium
AT403167B (de) 1994-11-14 1997-11-25 Immuno Ag Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems
JP3244391B2 (ja) 1994-12-08 2002-01-07 財団法人国際超電導産業技術研究センター 複合基板及びそれを用いた単結晶基板の製造方法
WO1996018734A1 (en) 1994-12-16 1996-06-20 Novartis Ag Production of recombinant secretory component
US5741705A (en) 1995-02-23 1998-04-21 Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc. Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides
EP0811056B1 (de) * 1995-02-23 2000-05-31 Quest International B.V. Peptide für gewebe- und zellkulturmedien
AU6125396A (en) 1995-06-07 1996-12-30 Novartis Ag Serum-free media for primitive hematopoietic cells and metho ds of use thereof
AUPN442295A0 (en) 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
JPH09107955A (ja) * 1995-10-24 1997-04-28 Kyowa Hakko Kogyo Co Ltd 動物細胞培養用培地
WO1997037547A1 (en) * 1996-04-09 1997-10-16 E.I. Du Pont De Nemours And Company Novel isoflavone-enriched soy protein product and method for its manufacture
US5851800A (en) * 1996-05-14 1998-12-22 Pharmacia & Upjohn Ab Process for producing a protein
JP2000517188A (ja) * 1996-08-30 2000-12-26 ライフ テクノロジーズ，インコーポレイテッド 無血清哺乳動物細胞培養培地およびその使用
EP0954563B1 (de) * 1996-10-10 2008-07-02 Invitrogen Corporation Tierzellkulturmedium mit pflanzlichen nährstoffen
JPH10211488A (ja) 1997-01-28 1998-08-11 Akai Electric Co Ltd 紫外線殺菌装置
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
EP1849860B1 (de) 1997-05-28 2010-11-17 Novartis Vaccines and Diagnostics S.r.l. Verfahren zur Herstellung eines immunogenen Faktors von Corynebacterium diphtheriae unter Verwendung eines Kulturmediums mit Hefeextrakt als Aminosäurenquelle und ohne Proteinkomplexe tierischer Herkunft
AT407255B (de) * 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
TR200000175T2 (tr) 1997-07-23 2001-01-22 Roche Diagnostics Gmbh Endogenik gen aktivasyonu ile eritropoietinin hazırlanması.
JPH11211488A (ja) 1998-01-21 1999-08-06 Matsushita Electric Ind Co Ltd 携帯情報端末を用いたデータ転送システム
FR2775983B1 (fr) * 1998-03-13 2000-11-10 Pasteur Merieux Serums Vacc Milieu et procede de propagation et de multiplication virales
WO1999057246A1 (en) 1998-05-01 1999-11-11 Life Technologies, Inc. Animal cell culture media comprising non-animal or plant-derived nutrients
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
DE59913565D1 (de) 1999-08-05 2006-07-27 Baxter Ag Rekombinanter stabiler zellklon, seine herstellung und verwendung
ES2272318T3 (es) 1999-08-25 2007-05-01 Immunex Corporation Composiciones y metodos para el cultivo celular mejorado.
CN1582333B (zh) 2000-09-25 2010-06-16 波利门科学生物免疫研究有限公司 活疫苗及生产方法
EP1208966A1 (de) 2000-11-27 2002-05-29 Cheng-Kun Liao Verfahren zur Herstellung eines Terrassentischs aus bruchsicherem Glas
NZ538094A (en) 2002-07-09 2007-01-26 Baxter Int Serum free and animal protein free culture medium for cultivation of cells
JP4316484B2 (ja) 2004-12-10 2009-08-19 シャープ株式会社 画像形成装置、トナー濃度制御方法、トナー濃度制御プログラムおよびその記録媒体

Also Published As

Publication number Publication date
US20030203448A1 (en) 2003-10-30
US20110287482A1 (en) 2011-11-24
US9441203B2 (en) 2016-09-13
US20150072415A1 (en) 2015-03-12
ES2265991T5 (es) 2017-05-03
PL215234B1 (pl) 2013-11-29
JP6348521B2 (ja) 2018-06-27
SI1220893T1 (sl) 2006-12-31
IL148642A (en) 2012-08-30
HU228210B1 (en) 2013-01-28
EP1220893B2 (de) 2016-08-31
AT409379B (de) 2002-07-25
JP2013135691A (ja) 2013-07-11
HUP0202759A3 (en) 2004-10-28
CY1106135T1 (el) 2011-06-08
CZ305307B6 (cs) 2015-07-29
US20170002392A1 (en) 2017-01-05
TR200200757T2 (tr) 2002-09-23
JP5777653B2 (ja) 2015-09-09
SK4002002A3 (en) 2002-07-02
DE60028989D1 (de) 2006-08-03
DK1220893T4 (en) 2016-12-05
RU2005123274A (ru) 2007-01-27
JP6467459B2 (ja) 2019-02-13
CN1318577C (zh) 2007-05-30
RU2266325C2 (ru) 2005-12-20
US20160369316A1 (en) 2016-12-22
AU780791B2 (en) 2005-04-14
WO2001023527A1 (en) 2001-04-05
US20080182297A1 (en) 2008-07-31
CN101173246B (zh) 2011-03-09
PT1220893E (pt) 2006-10-31
US8722406B2 (en) 2014-05-13
RU2009131610A (ru) 2011-02-27
IL250619A0 (en) 2017-06-29
JP2011135880A (ja) 2011-07-14
ES2265991T3 (es) 2007-03-01
HUP0202759A2 (hu) 2002-12-28
SK288059B6 (sk) 2013-03-01
CZ20021096A3 (cs) 2003-01-15
JP2003510070A (ja) 2003-03-18
EP1220893B1 (de) 2006-06-21
JP2017212977A (ja) 2017-12-07
PL355233A1 (en) 2004-04-05
JP5441288B2 (ja) 2014-03-12
IL219969A (en) 2017-06-29
DE60028989T3 (de) 2017-01-19
IL148642A0 (en) 2002-09-12
CA2385299A1 (en) 2001-04-05
EP1220893A1 (de) 2002-07-10
JP2019030306A (ja) 2019-02-28
DK1220893T3 (da) 2006-10-23
IL250619B (en) 2018-04-30
DE60028989T2 (de) 2007-01-25
IL219969A0 (en) 2012-06-28
US9982286B2 (en) 2018-05-29
CN1391604A (zh) 2003-01-15
CN101173246A (zh) 2008-05-07
JP2016127839A (ja) 2016-07-14
ATA165999A (de) 2001-12-15
RU2380412C2 (ru) 2010-01-27
AU7908300A (en) 2001-04-30
US8021881B2 (en) 2011-09-20
RU2536244C2 (ru) 2014-12-20

Similar Documents

Publication Publication Date Title
ATE331025T2 (de) Medium für die protein- und serumfreie zellkultur
BR0015374A (pt) Diferenciação hematopoiética de troncocélulas embriÈnicas humanas
NO984314L (no) Cellekulturmedium for pattedyrceller
BR0008772B1 (pt) vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica.
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
IS5905A (is) Alzheimer sekretasi
CA2058930A1 (en) Media for cell growth and method for making them
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
WO2002030958A3 (de) Casein-peptidfragmente mit wachstumsbeeinflussender aktivität auf zellkulturen
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
DK1495112T3 (da) Cellekulturmedium
WO2004031343A3 (en) Human foreskin cells suitable for culturing stem cells
PT1200561E (pt) Clone celular recombinante estavel, sua producao e utilizacao
AU2002361797A1 (en) Cell lines with latent immunodeficiency virus and methods of use thereof
CO2023015159A2 (es) Composición de hidrolizado celular a partir de células cultivadas y aplicaciones de la misma
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
WO2000006713A8 (en) Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
DK0858502T3 (da) Normale, neurale epitelprecursorceller
Barlow et al. Biosynthesis of plasminogen activator by tissue culture technique
DE69923595D1 (de) Herstellung von proteinen
ATE97958T1 (de) Zellenzuchtverfahren fuer die produktion von aktiviertem protein-c.
DK0550678T3 (da) Medier til dyrkning af Drosophila-celler
ATE470700T1 (de) Bazillus zelle für die herstellung von proteinen
EA200701000A1 (ru) Культуральная среда для клеток млекопитающих, не содержащая сыворотки
TW364924B (en) Three new cell lines derived from pupal ovaries of Spodoptera litura

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1220893

Country of ref document: EP